ÂÜÀòÂÒÂ×

Mr. Love has held financial, strategic and general senior management positions and invested in biotech companies for over twenty years. In addition to his role with BioKier, he is a co-founder and Vice President of Synereca Pharmaceuticals, a startup focused on the antibacterial field.

Prior to cofounding Synereca, his biotech roles included the development, funding, and collaborations of Ercole Biotech and its subsequent sale to AVI BioPharma; the management buyout of Medic Computer Systems; the $75 million IPO for Sphinx Pharmaceuticals; the $37 million IPO for what became Incara Pharmaceuticals; and the initial technology university spinout funding of Renaissance Cell Technologies. He received his MBA and undergraduate degrees from the University of North Carolina.